{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:45:42Z","timestamp":1793245542995,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":443,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.bbadis.2011.10.003","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T17:36:12Z","timestamp":1318872972000},"page":"625-630","source":"Crossref","is-referenced-by-count":294,"title":["Elevation of glutathione as a therapeutic strategy in Alzheimer disease"],"prefix":"10.1016","volume":"1822","author":[{"given":"Chava B.","family":"Pocernich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Allan","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2011.10.003_bb0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2001-3111","article-title":"Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"3","author":"Selkoe","year":"2001","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0010","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","article-title":"Oligomeric and fibrillar species of amyloid-\u03b2 peptides differentially affect neuronal viability","volume":"277","author":"Dahlgren","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jmb.2006.10.011","article-title":"Determining the critical nucleus and mechanism of fibril elongation of the Alzheimer's A beta(1\u201340) peptide","volume":"365","author":"Fawzi","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0025","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1042\/bj3550869","article-title":"In vitro studies of amyloid \u03b2-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692\u2192Gly) Alzheimer's disease","volume":"355","author":"Walsh","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0197-4580(02)00225-7","article-title":"Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1\u201342) in a transgenic Caenorhabditis elegans model","volume":"24","author":"Drake","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2011.10.003_bb0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1471-4159.2001.00451.x","article-title":"The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of A\u03b2(1\u201342)","volume":"78","author":"Lauderback","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0040","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","article-title":"Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress","volume":"32","author":"Butterfield","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nbd.2005.11.002","article-title":"Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease","volume":"22","author":"Butterfield","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0050","article-title":"Nutritional approaches to modulate oxidative stress in Alzheimer's disease","author":"Pocernich","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0055","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.bbalip.2010.02.005","article-title":"Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease","volume":"1801","author":"Butterfield","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2011.10.003_bb0060","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/jnr.21346","article-title":"Oxidative damage in mild cognitive impairment and early Alzheimer's disease","volume":"85","author":"Lovell","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0065","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s11064-004-7028-0","article-title":"Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products","volume":"29","author":"Sultana","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0070","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/sj.bjp.0702360","article-title":"ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1","volume":"126","author":"Renes","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0075","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1212\/WNL.51.6.1562","article-title":"Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease","volume":"51","author":"Lovell","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.003_bb0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0891-5849(98)00186-5","article-title":"Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity","volume":"25","author":"Xie","year":"1998","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0085","doi-asserted-by":"crossref","first-page":"26556","DOI":"10.1074\/jbc.M004097200","article-title":"Acute cadmium exposure inactivates thioltransferase (Glutaredoxin), inhibits intracellular reduction of protein-glutathionyl-mixed disulfides, and initiates apoptosis","volume":"275","author":"Chrestensen","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0090","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/jnr.21275","article-title":"An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach","volume":"85","author":"Newman","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0095","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s11064-009-9924-9","article-title":"Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis","volume":"34","author":"Di Domenico","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0100","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1471-4159.2002.01103.x","article-title":"Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71","volume":"82","author":"Castegna","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0105","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0891-5849(02)00914-0","article-title":"Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase l-1","volume":"33","author":"Castegna","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jchromb.2005.09.024","article-title":"Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around A beta(1\u201342)","volume":"833","author":"Sultana","year":"2006","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00019052-199812000-00011","article-title":"Glucose intolerance, cognitive impairment and Alzheimer's disease","volume":"11","author":"Vanhanen","year":"1998","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JAD-2010-1375","article-title":"Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration","volume":"20","author":"Butterfield","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0125","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1471-4159.2009.06397.x","article-title":"Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism","volume":"111","author":"Butterfield","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0891-5849(99)00269-5","article-title":"Age-associated decline in gamma-glutamylcysteine synthetase gene expression in rats","volume":"28","author":"Liu","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0135","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1089\/ars.2006.8.1975","article-title":"Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease","volume":"8","author":"Calabrese","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3233\/JAD-2009-1033","article-title":"Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental","volume":"17","author":"Lloret","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0145","first-page":"93","article-title":"Mild cognitive impairment: transition between aging and Alzheimer's disease","volume":"15","author":"Petersen","year":"2000","journal-title":"Neurologia"},{"key":"10.1016\/j.bbadis.2011.10.003_bb0150","first-page":"1891","article-title":"What is a mild cognitive impairment?","volume":"55","author":"Portet","year":"2005","journal-title":"Rev. Prat."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0155","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1007\/s11064-008-9593-0","article-title":"Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment","volume":"33","author":"Sultana","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0160","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.WNL.0000156156.13641.BA","article-title":"Evidence of increased oxidative damage in subjects with mild cognitive impairment","volume":"64","author":"Keller","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.003_bb0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2007.12.007","article-title":"Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease","volume":"30","author":"Reed","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2009.11.033","article-title":"Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease","volume":"469","author":"Padurariu","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0175","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archneur.59.6.972","article-title":"Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease","volume":"59","author":"Pratico","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0180","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/10715760802255764","article-title":"Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease","volume":"42","author":"Greilberger","year":"2008","journal-title":"Free. Radic. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2008-15110","article-title":"Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease","volume":"15","author":"Baldeiras","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JAD-2011-101425","volume":"24","author":"Sultana","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0195","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3233\/JAD-2010-091723","article-title":"Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment","volume":"21","author":"Baldeiras","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0197-0186(99)00126-6","article-title":"In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain","volume":"36","author":"Pocernich","year":"2000","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0205","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2007-1007174","article-title":"Glutathione therapy: from prodrugs to genes","volume":"18","author":"Anderson","year":"1998","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0210","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1046\/j.1471-4159.2003.01580.x","article-title":"The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice","volume":"84","author":"Farr","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0215","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0925-4439(99)00014-9","article-title":"In vivo modulation of rodent glutathione and its role in peroxynitrite-induced neocortical synaptosomal membrane protein damage","volume":"1453","author":"Koppal","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2011.10.003_bb0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0197-0186(01)00012-2","article-title":"Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease","volume":"39","author":"Pocernich","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0225","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/A:1019852720521","article-title":"3-nitropropionic acid-induced changes in bilayer fluidity in synaptosomal membranes: implications for Huntington's disease","volume":"27","author":"LaFontaine","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lfs.2003.06.025","article-title":"Delayed activation and regulation of MKK7 in hippocampal CA1 region following global cerebral ischemia in rats","volume":"74","author":"Zhang","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0235","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2006.06.042","article-title":"Protective effect of N-acetyl-l-cysteine on amyloid beta-peptide-induced learning and memory deficits in mice","volume":"1109","author":"Fu","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0240","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/jnr.22422","article-title":"Potential in vivo amelioration by N-acetyl-l-cysteine of oxidative stress in brain in human double mutant APP\/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment","volume":"88","author":"Huang","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0245","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1523\/JNEUROSCI.17-20-07736.1997","article-title":"Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant \u201capoptotic\u201d pattern of gene induction","volume":"17","author":"Estus","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0250","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/jnr.21710","article-title":"N-acetylcysteine prevents beta-amyloid toxicity by a stimulatory effect on p35\/cyclin-dependent kinase 5 activity in cultured cortical neurons","volume":"86","author":"Hsiao","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0255","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jnr.21909","article-title":"Different protection of K252a and N-acetyl-l-cysteine against amyloid-beta peptide-induced cortical neuron apoptosis involving inhibition of MLK3-MKK7-JNK3 signal cascades","volume":"87","author":"Xu","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0260","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1523\/JNEUROSCI.18-11-04042.1998","article-title":"Prevention of PC12 cell death by N-acetylcysteine requires activation of the Ras pathway","volume":"18","author":"Yan","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1010065103073","article-title":"N-acetyl-l-cystein downregulates beta-amyloid precursor protein gene transcription in human neuroblastoma cells","volume":"2","author":"Studer","year":"2001","journal-title":"Biogerontology"},{"key":"10.1016\/j.bbadis.2011.10.003_bb0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/156720506777632835","article-title":"RNA therapeutics directed to the non coding regions of APP mRNA, in vivo anti-amyloid efficacy of paroxetine, erythromycin, and N-acetyl cysteine","volume":"3","author":"Tucker","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0275","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1471-4159.2001.00090.x","article-title":"N-acetyl-l-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on beta-amyloid secretion and tau phosphorylation","volume":"76","author":"Olivieri","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0280","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1083\/jcb.200301115","article-title":"APP processing is regulated by cytoplasmic phosphorylation","volume":"163","author":"Lee","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0285","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature04543","article-title":"The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production","volume":"440","author":"Pastorino","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.10.003_bb0290","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.neurobiolaging.2005.05.005","article-title":"Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis","volume":"27","author":"Sultana","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2011.10.003_bb0295","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/JAD-2007-11203","article-title":"Proteomics analysis of the Alzheimer's disease hippocampal proteome","volume":"11","author":"Sultana","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0300","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.nbd.2010.04.011","article-title":"Preclinical Alzheimer disease: brain oxidative stress, A beta peptide and proteomics","volume":"39","author":"Aluise","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0305","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biomaterials.2009.09.014","article-title":"Inhibition of beta 1\u201340 amyloid fibrillation with N-acetyl-l-cysteine capped quantum dots","volume":"31","author":"Xiao","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbadis.2011.10.003_bb0310","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/jnen\/64.5.378","article-title":"Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging","volume":"64","author":"Wang","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0315","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbrc.2003.09.003","article-title":"Oxidized neprilysin in aging and Alzheimer's disease brains","volume":"310","author":"Wang","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0320","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JAD-2010-1226","article-title":"N-acetylcysteine prevents 4-hydroxynonenal- and amyloid-beta-induced modification and inactivation of neprilysin in SH-SY5Y cells","volume":"19","author":"Wang","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0325","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mrfmmm.2009.08.016","article-title":"Activated astroglia during chronic inflammation in Alzheimer's disease\u2014do they neglect their neurosupportive roles?","volume":"690","author":"Fuller","year":"2010","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0330","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1096\/fj.09-149997","article-title":"Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases","volume":"24","author":"Lee","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0891-5849(97)00137-8","article-title":"N-acetyl cysteine inhibits induction of no production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes","volume":"24","author":"Pahan","year":"1998","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0340","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1212\/WNL.57.8.1515","article-title":"Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease","volume":"57","author":"Adair","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.003_bb0345","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1533317508325094","article-title":"Efficacy of a vitamin\/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study","volume":"24","author":"Remington","year":"2009","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0350","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study","volume":"336","author":"Sano","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0355","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000048668","article-title":"Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease","volume":"45","author":"Le Bars","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bbadis.2011.10.003_bb0360","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0365","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/JAD-2008-15314","article-title":"Antioxidants in central nervous system diseases: preclinical promise and translational challenges","volume":"15","author":"Kamat","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0370","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1196\/annals.1427.010","article-title":"Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows","volume":"1147","author":"Pratico","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0375","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1073\/pnas.80.3.707","article-title":"Transport and direct utilization of gamma-glutamylcyst(e)ine for glutathione synthesis","volume":"80","author":"Anderson","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0380","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0735-1097(94)90125-2","article-title":"gamma-Glutamylcysteine ethyl ester for myocardial protection in dogs during ischemia and reperfusion","volume":"24","author":"Hoshida","year":"1994","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0385","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0006-2952(98)00361-X","article-title":"Protective effect of gamma-glutamylcysteinylethyl ester on dysfunction of the selenium-deficient rat heart","volume":"57","author":"Okamoto","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0390","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/jnr.10266","article-title":"Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress","volume":"68","author":"Drake","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0395","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/jnr.10810","article-title":"Elevation of mitochondrial glutathione by gamma-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress","volume":"74","author":"Drake","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0400","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/jnr.20394","article-title":"Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1\u201342)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease","volume":"79","author":"Boyd-Kimball","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0405","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/jnr.20393","article-title":"Gamma-glutamylcysteine ethyl ester protection of proteins from Abeta(1\u201342)-mediated oxidative stress in neuronal cell culture: a proteomics approach","volume":"79","author":"Boyd-Kimball","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0410","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1523\/JNEUROSCI.23-12-05088.2003","article-title":"Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity","volume":"23","author":"Abramov","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0415","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/107157602100006445","article-title":"Antioxidants inhibit the human cortical neuron apoptosis induced by hydrogen peroxide, tumor necrosis factor alpha, dopamine and beta-amyloid peptide 1\u201342","volume":"36","author":"Medina","year":"2002","journal-title":"Free. Radic. Res."},{"key":"10.1016\/j.bbadis.2011.10.003_bb0420","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/biof.5520170121","article-title":"Is glutathione an important neuroprotective effector molecule against amyloid beta toxicity?","volume":"17","author":"Barber","year":"2003","journal-title":"Biofactors"},{"key":"10.1016\/j.bbadis.2011.10.003_bb0425","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.2042-7158.2010.01122.x","article-title":"Effect of gamma-glutamylcysteine ethylester on the levels of c-fos mRNA expression, glutathione and reactive oxygen species formation in kainic acid excitotoxicity","volume":"62","author":"Turunc","year":"2010","journal-title":"J. Pharm. Pharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443911002262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443911002262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T20:12:39Z","timestamp":1713039159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443911002262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0925443911002262"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2011.10.003","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}